SCHEMBL5593783

SCHEMBL5593783

CC(c1cccc2ccccc12)n1sc(Cl)cc1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.41
HSD11B1 P28845 2/20 0.39
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
PIK3CB P42338 2/20 0.35
PIK3CA P42336 1/20 0.35
PDE2A O00408 1/20 0.35
GPR139 Q6DWJ6 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA9 Q16790 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL719504 0.68 HSD11B1 (0.47) NPBWR1HSD11B1CYP2C9CYP2C19ALDH1A1
SCHEMBL22342839 0.67 CYP2C9 (0.47) NPBWR1HSD11B1CYP2C9CYP2C19ALDH1A1
SCHEMBL20819792 0.67 CYP2C9 (0.47) NPBWR1HSD11B1CYP2C9CYP2C19ALDH1A1
SCHEMBL22319459 0.67 CYP2C9 (0.43) NPBWR1HSD11B1CYP2C9CYP2C19ALDH1A1
SCHEMBL6923510 0.67 POLB (0.49) NPBWR1HSD11B1CYP2C9CYP2C19ALDH1A1
SCHEMBL6923507 0.67 POLB (0.49) NPBWR1HSD11B1CYP2C9CYP2C19ALDH1A1
SCHEMBL14640465 0.67 KAT2B (0.47) NPBWR1ALDH1A1HTTPIK3CBPIK3CA
SCHEMBL22342841 0.66 ALDH1A1 (0.46) HSD11B1CYP2C9CYP2C19ALDH1A1CYP1A2
SCHEMBL25276584 0.66 HSD11B1 (0.57) HSD11B1CYP2C9CYP2C19ALDH1A1CYP1A2
SCHEMBL25276585 0.66 HSD11B1 (0.57) HSD11B1CYP2C9CYP2C19ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
WO-2007001932-A2 SUBSTITUTED ISOTHIAZOLONES AS INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 JANSSEN PHARMACEUTICA N.V. (BE) 2007-01-04 WO disclosed
US-20060293374-A1 Substituted isothiazolones JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293374-A1 Substituted isothiazolones LTB4R2, PTGES2, CYSLTR2 NPBWR1 1919/4885HSD11B1 250/4885CYP2C9 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.